ArticleWorld journal of clinical cases2025

Dual benefits of sodium-glucose cotransporter 2 inhibitors in metabolic diseases: Diabetes control and gout management.

Xiao-Peng FuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.